Navigation Links
Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests
Date:1/23/2012

ANN ARBOR, Mich., Jan. 23, 2012 /PRNewswire-USNewswire/ -- Researchers at the University of Michigan analyzed the tremendous cost of diagnosing peripheral neuropathy and found that less expensive, more effective tests are less likely to be used.

Almost one-quarter of patients receiving neuropathy diagnoses undergo high-cost, low-yield MRIs while very few receive low-cost, high-yield glucose tolerance tests, according to the study that will be published Jan. 23 in the Archives of Internal Medicine.

The research was led by Brian Callaghan, M.D., assistant professor of neurology at the University of Michigan Medical School.

Patients diagnosed with peripheral neuropathy typically are given many tests but physicians are highly variable in their approach, says Callaghan.

"We spend a lot of money to work up a diagnosis of neuropathy. The question is whether that money is well spent," Callaghan says.

For patients with peripheral neuropathy, the nerves that carry information to and from the brain don't work property. This commonly leads to tingling or burning in arms or legs and loss of feeling — and the symptoms can go from subtle to severe.

Diabetes is the most common cause of this type of nerve problem. Peripheral neuropathy is found in about 15 percent of those over age 40.

Researchers used the 1996-2007 Health and Retirement Study to identify individuals with a diagnosis of peripheral neuropathy. They focused on 15 relevant tests and examined the number and patterns of tests six months before and after the initial diagnosis.

"Our findings, that MRIs were frequently ordered by physicians, but a lower-cost glucose tolerance test was rarely ordered, show that there is substantial opportunity to improve efficiency in the evaluation of peripheral neuropathy," Callaghan says.

"Currently no standard approach to the evaluation of peripheral neuropathy exists. We need more research to determine an optim
'/>"/>

SOURCE University of Michigan Health System
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
3. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
4. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
5. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
6. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
7. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
8. Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR
9. Arcion Therapeutics Topical Gel Candidate, ARC-4558, Demonstrates Significant Pain Reduction in Phase 2b Trial for Painful Diabetic Neuropathy (PDN)
10. Arcion Therapeutics Receives FDA Fast Track Designation for ARC-4558 for the Treatment of Pain Associated with Painful Diabetic Neuropathy
11. Quark Pharmaceuticals Doses First Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patient in Stratum II of its Clinical Study of siRNA Drug Candidate QPI-1007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Md. , March 26, 2015  RegeneRx Biopharmaceuticals, ... it has received a patent acceptance notice from the ... 4 (TB4) to prevent or reduce tissue damage caused ... the case when cardiac vessels are opened after a ... when treating stroke victims. Damage can be ...
(Date:3/26/2015)... , March 26, 2015  Becton, Dickinson and ... it will commence offers to exchange all validly tendered ... CareFusion Corporation, a wholly owned subsidiary of BD, for ... the table below. A Registration Statement on Form S-4 ... New Notes was filed with the Securities and Exchange ...
(Date:3/26/2015)... , March 26, 2015 IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-three. ... the Company, commented, "On March 2, 2015, we committed ...
Breaking Medicine Technology:RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 2
... Higher ... to Standard Chemotherapy, SEATTLE, Nov. 11 Cell Therapeutics, ... the primary,efficacy endpoint of its phase III EXTEND (PIX301) trial ... based on a preliminary intent to treat efficacy analysis.,Patients randomized ...
... Pharmasset, Inc.,(Nasdaq: VRUS ), Roche (SWX: ROG) and ... first patients have been dosed in an innovative clinical,trial ... (HCV).,The trial (run in centers in Australia and New ... oral antiviral molecules in the absence,of interferon., The ...
Cached Medicine Technology:Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 2Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 3Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint 4Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 2Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 3Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 4Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 5
(Date:3/26/2015)... San Francisco, CA (PRWEB) March 26, 2015 ... webinars. These will be on the topics of the DAOM ... , The DAOM Program Overview Webinar will be hosted by ... program and provide the next steps on how to prepare ... to 12:30 p.m. March 25, March 27, April 1 and ...
(Date:3/26/2015)... New York (PRWEB) March 26, 2015 ... to move forward nationwide, with the issuance of ... in Pennsylvania and Louisiana. According to an Order ... multidistrict litigation established for Xarelto injury claims in ... will now allow plaintiffs to file cases directly ...
(Date:3/26/2015)... 26, 2015 Behavioral Research Group, ... announced the release of BathroomMap® , a new ... access to public restrooms for travelers, especially those with ... BathroomMap does not facilitate a paid, social or crowdsourced ... and rate local establishments that have clean, available restrooms ...
(Date:3/26/2015)... 26, 2015 Saving Moses is a ... is most needed but least available. As one of ... six clinics in the Benguela province of Angola to ... a recent visit to their clinics, staff employed the ... and their babies in a nation the The New ...
(Date:3/26/2015)... March 26, 2015 The Life ... “Introduction to Hyperbaric Medicine” course, which is accredited ... (UHMS) and the National Board of Diving & ... 40-hour course 4 times a year at several ... NY tri-state region; registration is available on-line at: ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4
... in Nine Infants, Especially in ... Premature and Minority Babies, ST. LOUIS, Oct. ... overall need for concern, according to new data,collected by the American ... The overall need,for concern has increased from one in 14 last ...
... Opportunities, LAS VEGAS, Oct. 26 As ... product pipeline and pharmaceutical contacts,Skinvisible, Inc. (OTC Bulletin ... a patented polymer delivery system for,topical skincare products, ... to its Advisory Board. Dr. Korkos is a ...
... in Animal Disaster,Assistance Offer Advice for Evacuees, Others, ... United Animal,Nations (UAN), the organization that pioneered ... emergency animal sheltering and disaster relief,services during Hurricane ... 2003, is offering financial assistance grants of up ...
... effort to raise,awareness about health plan quality, the Oct. ... feature a cover story entitled "America,s Best Health,Plans 2007." ... 50 commercial,health plans, as well as the top 25 ... the rankings are based upon data from the National,Committee ...
... State licenses MediMAR for 11 Behavioral Health ... Increasing its market,presence in behavioral health medication ... ) announced today that the Texas Department ... to license additional,components of Mediware,s ClosedLoop(TM) Medication ...
... 300 jobs, PITTSBURGH, Oct. 26 The ... Highmark Medicare Services Inc. as the new,Medicare Administrative ... Part B fee-for-service claims and other administrative activities ... Medicare Services will,process Medicare fee-for-services claims from hospitals ...
Cached Medicine News:Health News:2007 InfantSEE(R) Data Magnifies the Need for Early Eye and Vision Screenings for Infants, According to American Optometric Association 2Health News:2007 InfantSEE(R) Data Magnifies the Need for Early Eye and Vision Screenings for Infants, According to American Optometric Association 3Health News:Skinvisible Appoints Dr. George Korkos to Its Advisory Board 2Health News:Skinvisible Appoints Dr. George Korkos to Its Advisory Board 3Health News:United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets 2Health News:United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets 3Health News:United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets 4Health News:Blue Cross and Blue Shield of Florida NCQA/U.S. News & World Report Ranking 2Health News:Texas Health and Human Services Commission Adopts Mediware's ClosedLoop(TM) Medication Management Strategy 2Health News:Texas Health and Human Services Commission Adopts Mediware's ClosedLoop(TM) Medication Management Strategy 3Health News:Highmark Medicare Services Awarded New Contract from Centers for Medicare & Medicaid Services 2
... to Z Drug Facts produced by ... on thousands of medications. It provides ... effect, drug interactions, patient information and ... reference for physicians, students, residents, pharmacists, ...
Very concise book answering the question: "I've got a diagnosis, which drugs do I use?". All 15 chapters written by highly skilled US specialists...
... with Integrated Calculators, based on Davis's Drug ... advance in drug reference. DDGNIC contains the ... Guide (9th Edition) and has integrated calculation ... product merges many of the advantages of ...
Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
Medicine Products: